Stem/progenitor cell based therapeutic approach in our daily routine clinical practice, has been

elusive dream in medical sciences and improve

ment of stem cell homing as one of major challenges

in ...

Cell therapy is a modern approach in the treatment of most of the diseases which uses stem cells and it has been recently developed rapidly. Cell therapy has shown satisfactory results in this way. Our country, Iran, has ...

Berberine is one of the main alkaloids and it has been proved to have different pharmacologic effects, including prevention of cell cycle and also progression of apoptosis in various cancerous cells; however, its effects ...

Objective: The amniotic membrane (AM) is the innermost layer of the placenta and has unique biological and mechanical properties that make it a good biomaterial for tissue engineering. AM possesses most characteristics ...

امروزه استفاده از سلول های بنیادی خود بیمار، به عنوان یک استراتژی درمانی نوین در پزشکی ترمیمی، مطرح است. نشان داده شده است که سلول های بنیادی مزانشیمی با دارا بودن خصوصیات بنیادینگی، می توانند در ترمیم بافت، با اهداف کلینیکی ...

Objective(s): The limited homing potential of bone‐marrow‐derived mesenchymal stem cells (BM‐MSC)

is the key obstacle in MSC‐based therapy. It is believed that chemokines and chemokine receptor

interactions ...

Mesenchymal stem cells (MSCs) are considered

as promising candidates for new clinical trials of cell

therapies. Bone marrow (BM) was the first source reported

to contain MSCs; however, using it may be ...

type: Objective(s): Berberine is one of the main alkaloids and it has been proven to have different pharmacological effects including inhibition of cell cycle and progression of apoptosis in various cancerous cells; however, ...

Progenitor cells or mesenchymal stem cells are new cells, with renovation and regeneration ability and tissues repair. In recent years, administration of stem cells has been introduced to treat a variety of diseases including ...

Introduction: According to the National Institute of Health (NIH) it is estimated that 80 to 90 percent of potential therapeutics in preclinical testing runs into obstacles that prevent them from being translated to the ...